Loading...
Treatment of intrabony periodontal defects using rhFGF‐2 in combination with deproteinized bovine bone mineral or rhFGF‐2 alone: A 6‐month randomized controlled trial
AIM: To evaluate the use of recombinant human fibroblast growth factor (rhFGF)‐2 in combination with deproteinized bovine bone mineral (DBBM) compared with rhFGF‐2 alone, in the treatment of intrabony periodontal defects. MATERIALS AND METHODS: Patients with periodontitis who had received initial pe...
Na minha lista:
| Udgivet i: | J Clin Periodontol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6899590/ https://ncbi.nlm.nih.gov/pubmed/30758076 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcpe.13086 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|